ey0020.8-4 | Important for Clinical Practice | ESPEYB20
M Ghalwash , JL Dunne , M Lundgren , M Rewers , AG Ziegler , V Anand , J Toppari , R Veijola , W Hagopian , Type 1 Diabetes Intelligence Study Group
ey0019.10-2 | Reviews | ESPEYB19
EK Sims , REJ Besser , C Dayan , Rasmussen C Geno , C Greenbaum , KJ Griffin , W Hagopian , M Knip , AE Long , F Martin , C Mathieu , M Rewers , AK Steck , JM Wentworth , SS Rich , O Kordonouri , AG Ziegler , KC Herold
ey0019.15-6 | New Hormones | ESPEYB19
KJ Prentice , J Saksi , LT Robertson , GY Lee , KE Inouye , K Eguchi , A Lee , O Cakici , E Otterbeck , P Cedillo , P Achenbach , AG Ziegler , ES Calay , F Engin , GS Hotamisligil
ey0017.10-14 | (1) | ESPEYB17
AG Ziegler , K Kick , E Bonifacio , F Haupt , M Hippich , D Dunstheimer , M Lang , O Laub , K Warncke , K Lange , R Assfalg , M Jolink , C Winkler , P Achenbach , Fr1da Study Group
ey0020.8-9 | New Paradigms | ESPEYB20
K Warncke , A Weiss , P Achenbach , T von dem Berge , R Berner , K Casteels , L Groele , K Hatzikotoulas , A Hommel , O Kordonouri , H Elding Larsson , M Lundgren , BA Marcus , MD Snape , A Szypowska , JA Todd , E Bonifacio , AG Ziegler , GPPAD POInT Study Groups
ey0017.10-4 | (1) | ESPEYB17
CA Aronsson , H-S Lee , EM Hardaf Segerstad , U Uusitalo , J Yang , S Koletzko , E Liu , K Kurppa , PJ Bingley , J Toppari , AG Ziegler , J-X She , WA Hagopian , M Rewers , B Akolkar , JP Krischer , SM Virtanen , JM Norris , D Agardh , for the TEDDY Study Group
ey0017.10-8 | (1) | ESPEYB17
KC Herold , BN Bundy , SA Long , JA Bluestone , LA DiMeglio , MJ Dufort , SE Gitelman , PA Gottlieb , JP Krischer , PS Linsley , JB Marks , W Moore , A Moran , H Rodriguez , WE Russell , D Schatz , JS Skyler , E Tsalikian , DK Wherrett , AG Ziegler , CJ Greenbaum , Type 1 Diabetes TrialNet Study Group